Status:
COMPLETED
Adaptive CT Acquisition for Personalised Thoracic Imaging
Lead Sponsor:
University of Sydney
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Liverpool Cancer Therapy Centre
Conditions:
Cancer, Lung
Eligibility:
All Genders
18+ years
Brief Summary
In this trial, Respiratory Motion Guided (RMG) 4DCBCT will be implemented for the first time on lung cancer patients. RMG-4DCBCT adapts the image acquisition as the patient's breathing changes (i.e. i...
Detailed Description
Four dimensional cone beam computed tomography (4DCBCT) continues to play a pivotal role in the safe delivery of radiotherapy treatments for lung cancer patients. 4DCBCT meets exacting tumour localisa...
Eligibility Criteria
Inclusion
- Have the ability to give informed consent
- A diagnosis of lung cancer with an indication for radiotherapy either curative or palliative
- Radiotherapy treatment involving the routine acquisition of CBCT for patient setup provided that 4DCBCT is to be acquired during the course of treatment.
- At least two radiotherapy fractions during the course of treatment.
Exclusion
- Pregnant women.
- Patient who in the opinion of the treating physician could not tolerate the extra time on the treatment couch for two days of treatment.
Key Trial Info
Start Date :
August 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 19 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04070586
Start Date
August 21 2019
End Date
February 19 2021
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool Hospital
Liverpool, New South Wales, Australia, 2170